Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term entecavir treatment in HBV-related cirrhosis
ChiCTR-OCH-12002217Phase 4Completed
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir in hepatitis B-related liver cirrhosis and Chronic Hepatitis B (CHB) (2 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoints: HBV DNA, HBeAg seroconversion and 3 more. Started Jun 2006; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B-related liver cirrhosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OCH-12002217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-12002217.